Burkholderia cenocepacia (ATCC® BAA-245)

Strain Designations: LMG 16656  /  Type Strain: no  /  Biosafety Level: 2

Deposited As Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al.
Strain Designations LMG 16656
Isolation
Human clinical specimen, United Kingdom, 1989
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Genomovar III
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Antigenic Properties Genomovar III
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor BCCM/LMG Laboratory of Microbiology
Special Collection NCRR Contract
Isolation
Human clinical specimen, United Kingdom, 1989
References

Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.. Int. J. Syst. Bacteriol. 47: 1188-1200, 1997. PubMed: 9336927

Cross References

Nucleotide (GenBank) : AF148556 Burkholderia cepacia genomovar III 16S ribosomal RNA gene, partial sequence.

Nucleotide (GenBank) : AY278465 Burkholderia cenocepacia strain LMG 16656 outer membrane lipoprotein precursor (opcL) gene, partial cds.

Nucleotide (GenBank) : DQ359148 Burkholderia cenocepacia ribosomal S12 protein (rspS12) gene, complete cds; and ribosomal S7 protein (rspS7) gene, partial cds.